🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesBlood sugar used to spike to 200 after meals, now barely hits 120 — 12 month update Page 2

Blood sugar used to spike to 200 after meals, now barely hits 120 — 12 month update

Dr.LipidDallas Thu, Jan 9, 2025 at 11:45 AM 9 replies 1,723 viewsPage 2 of 2
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Jan 9, 2025 at 12:59 PM#6
Dr.LipidDallas said:
HbA1c reflects roughly three months of average glycaemia weighted toward the most recent weeks, which is why repeating it at six weeks tells you very…

My labs after 6 months on glycaemic control: A1C 5.4%, fasting glucose 84 mg/dL, fasting insulin 5 uIU/mL. My endo says these are "textbook perfect."

For context, my baseline A1C was 8.3% and fasting glucose was 129 mg/dL. The improvement has been dramatic and consistent.

Last edited: Jan 9, 2025 at 3:59 PM
30 0JenMemphis, pat_auckland, Dr.GastroMayo and 27 others
Reply Quote Save Share Report
TomFromTexas
Member
645
2,890
May 2024
Austin, TX
Jan 9, 2025 at 1:27 PM#7

Following on from Dr.MetabolicMD — and this may be the naive question:

What would you measure differently if you were starting again?

29 24Dr.NateNeph, PharmD_Rodriguez, julia.endo and 26 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Jan 9, 2025 at 1:55 PM#8
LabKate said:
My labs after 6 months on glycaemic control: A1C 5.4%, fasting glucose 84 mg/dL, fasting insulin 5 uIU/mL.

Complete metabolic panel trending on glycaemic control — sharing because comprehensive data helps everyone:

TestBaselineMonth 3Month 6Month 12
Glucose (fasting)120988882
Insulin (fasting)261285
HOMA-IR4.53.11.61.4
Uric Acid7.87.05.55.1

The insulin resistance improvement (HOMA-IR) is what my endo focuses on most. Going from 4.5 to near 1.0 is a metabolic transformation.

28 23DataDave, Dr.GutHealth, amsterdam_pete and 25 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Jan 9, 2025 at 2:23 PM#9
LabKate said:
My labs after 6 months on glycaemic control: A1C 5.4%, fasting glucose 84 mg/dL, fasting insulin 5 uIU/mL.

PCOS success story with glycaemic control: as someone with polycystic ovary syndrome, this medication has been transformative beyond weight loss.

After 10 months: periods became regular for the first time in years, testosterone levels normalized, acne cleared significantly, and — unexpectedly — I got pregnant naturally after 4 years of trying.

GLP-1 agonists address the insulin resistance at the root of PCOS. For PCOS patients, this isn't "just" a weight loss drug — it's treating our underlying metabolic dysfunction.

Last edited: Jan 9, 2025 at 4:23 PM
27 22lori_vegas, Dr.PulmRoch, maya_sedona and 24 others
Reply Quote Save Share Report
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Jan 9, 2025 at 4:36 PM#10
PharmacoVig_BOS said:
Complete metabolic panel trending on glycaemic control — sharing because comprehensive data helps everyone: Test Baseline Month 3 Month 6 Month 12…

Insulin sensitivity test (HOMA-IR) on glycaemic control — arguably the most important metabolic marker most people aren't tracking:

HOMA-IR = (fasting insulin × fasting glucose) ÷ 405

My numbers: Baseline HOMA-IR = 4.7 (insulin resistant) → Current = 1.5 (insulin sensitive)

Anything above 2.0 indicates insulin resistance. The goal is below 1.5. GLP-1 agonists address the root metabolic dysfunction, not just the symptoms. This is why they work so much better than calorie restriction alone.

37 10TrialTracker_MD, JennaRN, LabKate and 34 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register